Transamerica No-Medical-Exam Term Life Insurance Fit Review

Research Snapshot

Why Transamerica Qualified for This Study

Questions This Section Answers

• Is Transamerica a good choice for no-medical-exam term life insurance?
• How many AI platforms named Transamerica for no-medical-exam term life insurance?

Transamerica qualified because it was named by two of the seven platforms during ranking discovery and because six of the seven platforms returned a usable fit assessment for this use case. The two platforms that named it placed it at rank 6 (anthropic) and rank 5 (grok), producing an average listed rank of 5.5 ^[1].

The fit ratings were not uniform. Google rated Transamerica a "strong" fit, openai, anthropic, grok, and perplexity rated it "good," and kimi rated it "uncertain" ^[3]. That spread matters: the entity cleared the study's minimum-mention threshold, but it did not appear on every platform's shortlist, and one platform could not verify its no-exam specifics at all.

Transamerica is an established carrier. Independent sources describe it as operating since 1904 and backed by the Aegon global insurance conglomerate ^[4]. It holds an A (Excellent) financial-strength rating from AM Best according to multiple independent reviews ^[5]. Those facts establish eligibility for the study; they do not establish that Transamerica is the best no-exam option for any particular buyer.

The Product, Model, Plan, or Service Most Relevant to No-Medical-Exam Term Life Insurance

Questions This Section Answers

• Which Transamerica plan should a buyer choose for no-medical-exam term life insurance?
• Does Transamerica's Trendsetter Super or Trendsetter LB allow coverage without blood or urine testing?

The relevant products are Transamerica's Trendsetter Super and Trendsetter LB term policies, both described as using accelerated or nonmedical underwriting for qualifying applicants ^[8]. Trendsetter LB adds living-benefit features beyond the standard policy, including accelerated death benefits for qualifying terminal, chronic, or critical illness ^[11].

Reported term periods include 10, 15, 20, 25, and 30 years ^[13]. Reported applicant ages run from 18 to 80 ^[15]. Coverage starts at $25,000, with Trendsetter Super described as reaching $10 million or more under full underwriting and Trendsetter LB capped at $2 million ^[17].

The no-exam pathway is not a separate simplified-issue product. It is an underwriting route inside the Trendsetter line. Transamerica's own materials state that term life includes no medical exam up to $2 million for qualified applicants and conversion without another medical exam ^[18]. A company field guide describes nonmedical underwriting as based on health questions and fast data results, available to U.S. and Puerto Rico residents ^[20].

One naming caveat: public sources differ on exact product naming and underwriting rules by state and policy form, and the current September 2026 product availability and underwriting guide for every state was not publicly verified ^[9].

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree on about Transamerica no-medical-exam term life insurance?
• How much coverage can a healthy buyer get from Transamerica without a medical exam?

The clearest cross-platform agreement is that Transamerica offers a no-exam term pathway with a reported ceiling of up to $2 million for qualifying applicants. This appears in company-owned material and in independent reviews across multiple platforms ^[22].

A second area of agreement is the underwriting method. Platforms consistently describe a process built on health questions plus third-party data rather than a paramedical exam. Named sources include Medical Information Bureau screening, prescription-drug history, motor-vehicle records, and electronic health data ^[28]. Transamerica's own underwriting FAQ describes use of application answers and medical questions and notes that automated or nonmedical applications can receive additional requirements ^[33].

A third agreement concerns pricing direction. Independent analyses characterize Transamerica's term pricing as competitive, with one review reporting a MoneyGeek score of 4.4 out of 5 and ranking it among the cheapest carriers ^[34]. Sample figures reported by independent sources include $37 per month for a 40-year-old nonsmoking woman and $46 per month for a man, both for $500,000 of 20-year coverage ^[37]. A separate independent review reports an average annual premium of $273, almost 26% below a stated national average of $382 ^[39]. Grok-reported figures differ slightly, citing roughly $41 per month for women and $50–$51 for men on a comparable profile ^[40].

A fourth agreement is that exam-free approval is conditional. Platforms describe the possibility of escalation to a medical exam, labs, attending-physician statements, or additional records when automated underwriting does not resolve the risk ^[42].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Is Transamerica's no-exam coverage limit $1 million or $2 million?
• Why did one AI platform rate Transamerica uncertain for no-medical-exam term life insurance?

The largest conflict is the no-exam coverage ceiling. Current independent sources report up to $2 million without an exam, while older Transamerica documents describe accelerated programs with limits up to $1 million ^[45]. Google-reported material adds a further layer, describing expanded nonmedical limits of up to $2 million for ages 18–45 and $1 million for ages 46–55 ^[48]. The current maximum for a specific age, state, product, and risk class is therefore unclear from public sources and should be verified directly.

Platforms also disagreed on fit. Kimi rated Transamerica "uncertain," stating that no independent 2026 source it retrieved specifically confirmed Transamerica's no-exam term availability, features, or competitiveness, and noting that a 2026 ranking it reviewed listed Nationwide, Banner Life, Ethos, Mutual of Omaha, and USAA without Transamerica ^[49]. That is a genuine evidence gap, not a finding that Transamerica lacks a no-exam product.

Approval-timeline reporting is inconsistent. One source indicates coverage typically within 14 days of application submission for no-exam products ^[51]. Another describes accelerated nonmedical applications issuing in as little as 48 hours when no extra requirements are needed ^[52]. A third describes no-exam applications potentially completing in roughly two weeks ^[53]. These are not necessarily contradictory, but no platform supplied a guaranteed service level.

Financial-strength framing differs by context. Some sources describe the AM Best A rating as "excellent" and indicating strong claims-paying ability ^[54]. Others note it is below the A+ or A++ ratings held by top competitors ^[56]. Both statements are factually accurate depending on the comparison set.

Customer-experience findings are directionally consistent but vary in detail. Independent sources report a NAIC complaint index of 3.86, nearly four times the industry average of 1.0 ^[59]. One source reports a 2025 complaint rate over four times higher than expected ^[62]. A J.D. Power score of 604 is reported as ranking 18th out of 21 carriers ^[63]. The specific nature of complaints is not uniformly detailed across sources.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What data sources does Transamerica use to underwrite no-exam term life insurance?
• Does Transamerica's no-exam term policy include living benefits or conversion rights?

Transamerica's no-exam pathway relies on data the target buyer has already said they are comfortable providing. Named sources include MIB screening, prescription-drug database checks, motor-vehicle records, and electronic health data ^[64]. One independent review states Transamerica will access electronic databases with authorization to verify information and assess risk ^[68].

Living benefits are a differentiator on the LB version. Trendsetter LB policyholders can receive accelerated death benefits, and independent sources describe coverage for qualifying terminal, chronic, and critical illness ^[69]. Google-reported material states these living benefits are integrated into base premiums at no extra upfront cost, though that claim is platform-reported and should be confirmed in the illustration ^[71].

Conversion rights appear across platforms. Independent sources state Transamerica term policies can be converted to permanent coverage without a new medical exam, and that conversion is valuable if health changes during the term ^[72]. Google-reported material describes a conversion rider permitting partial or full conversion before age 70, or 75 for Preferred Plus ^[71]. Conversion deadlines, eligible permanent products, and conversion pricing rules were not consistently specified and should be verified.

Contract mechanics are documented in agent-facing guides. Trendsetter Super Series products include a free-look period, typically 10 days in most states, during which premiums are refunded if the policy is rescinded, and a 31-day grace period following each premium due date during which the policy remains in force ^[76].

One structural limitation: online quotes are reported as available only for Trendsetter Super, and completing the application generally requires agent involvement rather than a direct online purchase ^[81].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Transamerica no-medical-exam term life insurance cost per month?
• What fees and contract terms should a buyer confirm before signing a Transamerica no-exam policy?

Exact no-exam premiums are not publicly verifiable for a generic buyer profile, and pricing confidence across platforms was low to moderate. Published independent examples describe competitive term pricing, but they are not a substitute for an individualized quote and may not represent the no-exam underwriting class ^[85].

Reported sample rates cluster in the high $30s to low $50s per month for a 40-year-old nonsmoker with $500,000 of 20-year coverage. Anthropic-reported figures are $37 per month for women and $46 for men, described as 21% below a national average ^[87]. Grok-reported figures are approximately $41 for women and $50–$51 for men, with no-exam pricing described as roughly 5–10% above fully underwritten rates for healthy applicants ^[90]. A separate independent review reports an average annual premium of $273 against a stated national average of $382 ^[92]. These figures come from different sources and profiles and should not be treated as a single rate table.

Fee disclosure is thin. No application fees were disclosed for no-exam underwriting in the reviewed sources, and no separate consumer-paid medical-exam fee was identified for the no-exam path. Google-reported material cites an annual policy fee of $30 to $60 for face amounts under $100,000 and an administrative charge, described as $100 and up to $400 in California, for accelerating chronic illness benefits after the initial payment ^[93]. Those figures are platform-reported and should be confirmed in the policy illustration.

Contract terms reported across platforms include level premiums locked for the initial term of 10, 15, 20, 25, or 30 years, with premiums increasing on an attained-age basis after the level period ends. Rider costs vary by rider type, coverage amount, and state approval, and substandard rate tables are described at 25% per table above Standard rates. Grok-reported material states the LB version may price roughly 10–20% higher than Super for the living-benefit feature.

Best Suited For

Questions This Section Answers

• Who is Transamerica's no-medical-exam term life insurance best for?
• Is Transamerica a good fit for a healthy buyer who wants up to $2 million without an exam?

Transamerica is best suited to healthy applicants who prioritize no blood or urine testing and are willing to complete a health interview and authorize prescription-history, public-record, or other underwriting checks.

The strongest fit profiles reported across platforms are healthy consumers aged 18 to 80 who want coverage between roughly $100,000 and $2 million without a medical exam, who have clean health profiles unlikely to trigger supplemental underwriting requests, and who are comparing quotes through an independent agent rather than relying on a single insurer. Google-reported material narrows the highest no-exam limits to applicants aged 18–45 for up to $2 million and 46–55 for up to $1 million ^[94].

Price-conscious buyers are a recurring theme. Independent analyses describe Transamerica as ranking among the cheapest term carriers, which matters if the buyer's primary driver is premium rather than digital convenience or service responsiveness ^[95].

Buyers who want living benefits bundled into the base policy are also a fit, provided they select Trendsetter LB rather than Trendsetter Super ^[98].

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Transamerica for no-medical-exam term life insurance?
• Is Transamerica a bad choice for a buyer who needs guaranteed exam-free approval?

Transamerica is probably not the best choice for applicants who require guaranteed approval or guaranteed exam-free issuance. No-exam issuance is conditional, and applicants can be redirected to an exam, labs, records, or declined if the risk is deemed too high for the no-exam product ^[100].

Buyers prioritizing the strongest reported customer-service or complaint profile over underwriting convenience should look elsewhere. Independent sources report a NAIC complaint index of 3.86 against an industry average of 1.0 and a J.D. Power score of 604 ranking 18th out of 21 carriers ^[103].

Applicants who want instant online approval without agent contact are a poor fit. Online quotes are reported as available only for Trendsetter Super, and the full application must be completed through a licensed independent agent ^[107].

New York applicants may be excluded. At least one independent review reports that Transamerica term life is unavailable in New York, and product availability must be confirmed by state ^[107].

Buyers seeking the highest available financial-strength ratings should note that Transamerica's AM Best A rating trails the A+ or A++ ratings held by top competitors ^[111].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Transamerica for a buyer who needs more than $2 million without an exam?
• When should a buyer choose a digital-first carrier instead of Transamerica for no-exam term life insurance?

Another carrier may be better in several specific situations reported across platforms.

When the buyer needs more than $2 million without an exam, alternatives are reported with higher ceilings. Penn Mutual is described as offering up to $10 million no-exam, and Ladder is described as offering $100,000 to $3 million without a medical exam ^[114].

When the buyer prioritizes a seamless digital experience and instant online approval, Nationwide is described with a 0.08 NAIC complaint index and a fully digital application for ages 21–55, and Ladder is described as issuing most policies within minutes online ^[115].

When the buyer needs the absolute lowest rates regardless of service, Banner Life is described as cheapest in category with average rates of $41 per month for women and $51 for men.

When the buyer is a smoker seeking no-exam coverage, Pacific Life is described as offering up to $2 million no-exam for smokers through its Swift Sailing program.

When the buyer wants living-benefit riders included without extra cost, Mutual of Omaha Term Life Express is described as including terminal, chronic, and critical illness riders with no-exam coverage to $550,000 ^[116].

When the buyer has a complex health history, prescreening with a broker before application is advised, because Transamerica may not classify favorably relative to competitors for specific conditions.

When the buyer wants fully published, easily comparable prices before applying, another insurer with more transparent online quoting may be better suited.

Questions to Verify Before Buying

The following items were flagged across platforms as unresolved or quote-specific. They are verification prompts, not findings.

• For my state, age, face amount, term, and health profile, is Trendsetter Super or Trendsetter LB available without blood or urine testing ?
• What is the current maximum no-exam face amount for my exact application, given the conflict between $2 million and $1 million reporting ^[117]?
• Will prescription databases, electronic health records, medical-information databases, consumer reports, motor-vehicle records, or an attending-physician statement be used ^[118]?
• Under what circumstances can Transamerica later require an exam, labs, or medical records ^[119]?
• What is the guaranteed monthly or annual premium, and is it level for the entire selected term ?
• Are there policy or rider charges, especially for living benefits, and what is the annual policy fee for my face amount ^[120]?
• What are the conversion rights, deadline, eligible permanent products, and conversion pricing rules ?
• Is the policy issued by Transamerica Life Insurance Company or Transamerica Financial Life Insurance Company, and what are the current ratings and complaint data for that entity ?
• Can the application and delivery be completed electronically, and what is the expected decision timeline ^[121]?
• What are the free-look, cancellation, lapse, reinstatement, renewal, and contestability provisions ^[122]?

Final AI Consensus Verdict

Transamerica is a good fit, with verification required, for a healthy U.S. consumer seeking No-Medical-Exam Term Life Insurance. Six of seven included platforms returned a usable fit assessment, and five of those six rated the fit good or strong. The consensus strengths are a reported no-exam ceiling of up to $2 million for qualifying applicants, an accelerated underwriting process built on health questions and third-party data the target buyer has already agreed to provide, multiple term lengths from 10 to 30 years, conversion to permanent coverage without a new exam, and independent descriptions of competitive term pricing.

The consensus limitations are equally clear. Exam-free issuance is conditional and can escalate to a full exam or additional records. Public coverage limits conflict between newer independent reporting and older Transamerica materials. No verified public rate table exists for this use case. Independent sources report elevated complaint levels and below-average customer-experience scores. The application process generally requires agent involvement rather than a direct online purchase. One platform rated the fit uncertain because it could not verify Transamerica's no-exam specifics from independent 2026 sources.

Platform agreement does not prove product quality. It shows that multiple research systems converged on similar reported facts. Buyers should compare Transamerica against at least one digital-first carrier and one A+ or A++ rated carrier before committing, and should confirm the current no-exam maximum, guaranteed premium, and state availability directly. The broader No-Medical-Exam Term Life Insurance consensus index covers how other carriers scored on the same criteria.

How This Review Was Produced

This review was produced from a structured research run dated 2026-09-20 covering seven AI platforms. Each platform received the same buyer prompt describing a healthy consumer who wants term life insurance without a traditional paramedical examination involving blood or urine testing, is comfortable answering health questions and allowing electronic health, prescription, or consumer data for underwriting, and wants competitive pricing, meaningful coverage amounts, a reputable carrier, and an efficient application process.

Platforms first produced a ranked list of recommended carriers. Transamerica was named by two of the seven platforms during that ranking stage, at ranks 6 and 5. Platforms then produced detailed fit assessments for the entity, including product identification, use-case findings, pricing and terms, limitations, and verification questions. Six of the seven platforms returned a usable fit assessment.

This report evaluates Transamerica only for the no-medical-exam term life insurance use case. It is not a broad company review and does not assess Transamerica's other insurance or financial products. All factual claims are attributed to the platform that supplied them using parenthetical citation IDs. Company-owned sources are distinguished from independent sources in the Sources section. The life insurance category directory lists related coverage areas.

Methodology Limitations

Six of seven included platforms returned a usable fit assessment. The fit findings should not be described as unanimous, and platform_mentions counts only platforms that named the entity during ranking discovery, not platforms that assessed fit.

Platform-reported research dates differ from the authoritative run date. All six platforms that returned assessments reported a research date of 2026-09-21, while the run research date is 2026-09-20. Platform-reported dates are provenance metadata and do not independently prove freshness.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts. Claims from platforms without search capability, or claims lacking a supporting citation, require explicit verification before being described as current facts.

Conflicting product names, pricing, and capabilities were not resolved by guessing. Where sources conflicted, the conflict is described and the buyer is directed to verify. The no-exam coverage ceiling conflict between $2 million and $1 million reporting is the most material unresolved item.

No authoritative public premium schedule was found for the exact buyer profile. Pricing confidence was rated low by openai and perplexity and moderate by anthropic and grok. No platform reported personal testing, customer experience, or independent verification of Transamerica's underwriting outcomes.